• 1. An assay for the enzyme N-acetyl-β-d-glucosaminidase (NAGase) based on electrochemical detection using screen-printed carbon electrodes (SPCEs)
  R. M. Pemberton,J. P. Hart,T. T. Mottram Analyst, 2001,126, 1866-1871
• 2. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 3. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 4. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 5. An intermolecular C–H oxidizing strategy to access highly fused carbazole skeletons from simple naphthylamines?
  Christian K. Rank,Alexander W. Jones,Tatjana Wall,Patrick Di Martino-Fumo,Sarah Schr?ck,Markus Gerhards,Frederic W. Patureau Chem. Commun., 2019,55, 13749-13752

Adenosine-13C10-15N5: A Sophisticated Isotope-Labeled Compound for Advanced Research Applications

Adenosine-13C10-15N5, a meticulously crafted isotope-labeled derivative of the naturally occurring nucleoside Adenosine, represents a significant advancement in the field of biochemical and pharmaceutical research. This compound, identified by its CAS number 202406-75-5, is distinguished by the incorporation of stable isotopes Carbon-13 and Nitrogen-15 into its molecular structure. Such isotopic labeling not only enhances the compound's utility in metabolic studies but also opens new avenues for understanding the intricate mechanisms of cellular processes.

The strategic substitution of Carbon-13 and Nitrogen-15 at specific positions within the Adenosine molecule allows researchers to trace metabolic pathways with unprecedented precision. This is particularly valuable in studying the role of Adenosine in various physiological and pathological conditions, including cardiovascular diseases, neurodegenerative disorders, and cancer. The use of 13C labeled compounds enables the application of carbon dioxide labeling techniques, which are increasingly popular in metabolic flux analysis and dynamic studies.

Recent advancements in magnetic resonance imaging (MRI) have further highlighted the potential of isotope-labeled nucleosides like Adenosine-13C10-15N5. The unique magnetic properties of Carbon-13 allow for high-resolution spectroscopic analysis, making this compound an invaluable tool for non-invasive imaging techniques. Researchers are exploring its applications in positron emission tomography (PET) and other imaging modalities to visualize biological processes with greater clarity. The incorporation of Nitrogen-15 also enhances the compound's detectability in nuclear magnetic resonance (NMR) spectroscopy, facilitating detailed structural elucidation.

In the realm of drug development, Adenosine-13C10-15N5 serves as a critical intermediate in synthesizing novel therapeutic agents. Its labeled structure provides a reliable framework for studying drug metabolism and pharmacokinetics. By tracking the movement of labeled atoms through metabolic pathways, scientists can gain insights into how drugs are processed within the body. This information is pivotal for optimizing drug formulations and improving therapeutic efficacy.

The compound's versatility extends to its use in enzyme kinetics studies. The stable isotopes incorporated into its structure allow researchers to monitor enzyme-catalyzed reactions with high sensitivity. This capability is particularly useful in investigating enzymes involved in energy metabolism, such as adenosine kinase and adenosine deaminase. Understanding these enzymatic processes at a molecular level can lead to the discovery of novel targets for therapeutic intervention.

Moreover, Adenosine-13C10-15N5 has shown promise in clinical trials as a diagnostic tool for assessing tissue perfusion and oxygenation. Its ability to be selectively taken up by tissues under specific conditions makes it an ideal candidate for non-invasive monitoring of physiological states. Early studies indicate that it may help in diagnosing conditions such as ischemia and hypoxia by providing real-time data on tissue oxygen levels.

The synthesis of Adenosine-13C10-15N5 involves sophisticated chemical methodologies that ensure high purity and yield. Advanced techniques such as isotopic exchange reactions and chiral resolution are employed to achieve the precise labeling required for its applications. These synthetic strategies not only enhance the compound's quality but also contribute to the development of scalable production processes suitable for industrial applications.

The growing interest in isotope-labeled compounds underscores their importance in modern biomedical research. As technology advances, new methodologies for incorporating stable isotopes into complex molecules like nucleosides continue to emerge. This trend bodes well for future research endeavors, where compounds like Adenosine-13C10-15N5 will play an increasingly pivotal role in unraveling biological mysteries and advancing therapeutic strategies.

In conclusion, Adenosine-13C10-15N5 represents a cornerstone in biochemical research, offering unparalleled insights into cellular metabolism, drug development, and diagnostic applications. Its unique isotopic composition and versatile utility make it an indispensable tool for scientists striving to push the boundaries of medical science. As research progresses, we can expect even more innovative uses for this remarkable compound, further solidifying its place as a cornerstone of modern biomedical investigation.

• 24356-66-9(Vidarabine monohydrate)
• 10279-87-5(9H-Purin-6-amine, 9-b-D-gulofuranosyl-)
• 3080-29-3(L-Adenosine)
• 4754-39-6(5'-Deoxyadenosine)
• 5536-17-4(Vidarabine)
• 58-61-7(Adenosine)
• 10300-22-8(3'-O-Methyladenosine)
• 10279-89-7(9H-Purin-6-amine, 9-b-D-allofuranosyl-)
• 10279-88-6(9H-Purin-6-amine, 9-b-L-gulofuranosyl-)
• 2006-02-2(9H-Purin-6-amine,9-arabinofuranosyl-)